This IDC Health Insights report provides an assessment of where the life science manufacturing and supply chain BPO market is going, how the major vendors compare with each other, and what criteria are most important for life science companies to consider when selecting an IT outsourcing vendor.
Eric Newmark, program director of IDC Health Insights' Commercial Life Sciences research, noted, "Manufacturers are under increasing market pressure to improve enterprise agility, develop drugs faster, and eliminate waste from all manufacturing and supply chain–related processes. Companies are also faced with increased regulatory pressure and strengthening generic competition, which are driving industry consolidation as companies look to capitalize on cross-company synergies and overlapping overhead structures. Within the life sciences, there continues to be strong demand for external partners that have strong life science–specific industry expertise and can help achieve these goals in a cheaper, more flexible fashion. If you are looking for assistance in selecting a third-party service provider for manufacturing or supply chain BPO, the guidance provided in this IDC MarketScape is a great place to start."